• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Megasoft Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 8034.0
  • ISIN : INE933B01012
115.91 2 (2.00%)
  • As on 02 Aug 2025 (EOD)
  • Today’s Low

    115.91
  • Today’s High

    115.91
  • Open

    115.91
  • Perv Close

    113.64
  • 52W Low

    49.06
  • 52W High

    115.91

Key Indicators

  • P/E(TTM)

    100.70

  • Mar.Cap (₹Cr.)

    855.07

  • Div & Yield %

    0.00

  • Book Value(₹)

    24.99

  • Debt-Equity Ratio

    2.00

  • AGM Date

    01-Aug-2025

  • EPS

    1.15

  • P/E Ratio

    100.70

Financials Ratios

  • Debt-Equity Ratio

    0.92

  • Mar.Cap (₹Cr.)

    855.07

  • RONW (%)

    4.77

  • ROCE (%)

    7.72

Score Board

  • Equity (₹ in Cr.)

    73.77

  • BV (₹)

    25.00

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    8.48

  • NP Var(%)

    12.0

  • Div%

    0.0

  • CPS (₹)

    1.80

  • EPS (₹)

    1.10

  • Traded Value (₹ in Lakhs)

    854.26

  • 52 Week High

    115.91

  • 52 Week Low

    49.06

  • Price BSE

    116.0

  • Price NSE

    116.00

  • Market Capital( in Cr.)

    854.26

  • P/C Ratio

    66.10

  • P/E Ratio

    101.00

  • Price Vs.BV

    1.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 0.00 1.97 14.11 16.47 20.34 23.64
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 1.97 14.11 16.47 20.34 23.64
Other Income 37.35 43.82 154.25 6.86 6.50 10.14
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 37.35 45.79 168.36 23.33 26.84 33.78
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.01 0.09 0.35 0.50 0.68 0.70
Employee Cost 2.06 3.86 10.35 8.57 7.76 11.53
Other Manufacturing Expenses 0.26 1.20 2.10 1.73 1.92 3.17
Selling and Administration Expenses 6.27 12.28 4.66 3.45 5.22 5.58
Miscellaneous Expenses 0.30 3.14 139.25 1.52 3.63 7.30
Employee Benefit Expenses 2.06 3.86 10.35 8.57 7.76 11.53
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 8.90 20.58 156.71 15.78 19.21 28.28
Operating Profit 28.45 25.22 11.66 7.55 7.64 5.49
Interest 17.06 10.90 2.06 2.74 3.67 3.73
Gross Profit 11.39 14.32 9.60 4.81 3.97 1.76
Depreciation 3.19 2.84 3.39 3.43 3.45 0.98
Profit Before Tax 8.20 11.48 6.21 1.38 0.52 0.78
Current Tax 0.64 0.00 0.00 0.00 0.00 0.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.62 -0.01 -0.04 0.34
Reported Net Profit 7.56 11.48 5.58 1.39 0.56 0.41
Extraordinary Items 0.00 1.05 3.08 0.00 0.00 0.00
Adjusted Net Profit 7.56 10.43 2.50 1.39 0.56 0.41
Adjustment below Net Profit 0.00 0.03 0.00 0.00 0.00 0.00
P & L Balance brought forward 66.05 54.55 71.18 69.79 69.23 68.82
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 22.21 0.00 0.00 0.00
P & L Balance carried down 73.61 66.05 54.55 71.18 69.79 69.23
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.02 1.56 0.76 0.31 0.13 0.09
Earnings Per Share(Adj)-Unit Curr 1.02 1.56 0.76 0.26 0.11 0.08
Book Value 23.83 22.81 21.25 27.52 27.22 27.09
Book Value(Adj)-Unit Curr 23.83 22.81 21.25 23.20 22.94 22.83

Shareholding Pattern

  • Promoter Group

    35.07%

  • Public Share Holding

    64.93%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 25,873,115 35.07 25,873,115 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 25,873,115 35.07 25,873,115 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 12 0.00 12 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 141,903 0.19 141,903 5
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 141,915 0.19 141,915 6
2] Non Institution
Bodies Corporate 2,501,701 3.39 2,500,514 309
Clearing Members 9 0.00 9 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,519,710 4.77 3,497,649 411
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,076,067 2.81 2,076,067 700
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 21,641,888 29.34 20,500,688 275
Individuals holding nominal share capital up to Rs. 1 lakh 17,957,879 24.34 17,633,539 30,870
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 105 0.00 105 2
Others 0 0.00 0 0
Sub Total 47,755,011 64.74 46,266,223 32,584
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 73,770,041 100.00 72,281,253 32,591

Company Background

Megasoft LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Megasoft Ltd
  • BSE Code : 8034.0
  • ISIN : INE933B01012
  • Incorporation Year

    1999

  • Registered Office

    85 Kutchery Road
    Mylapore, Chennai,
    Tamil Nadu-600004

  • Telephone

    91-44-24616768

  • FAX

    91-44-24617810

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    N C Rajagopal & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Megasoft Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Megasoft 115.80 37.35 0.00 100.70 7.42
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10